What is Tarpeyo, and what does “Japan NDA” mean?
Tarpeyo is the brand name for budesonide (a corticosteroid). When people search for “Tarpeyo Japan NDA,” they usually mean whether the company has filed a New Drug Application (NDA) in Japan for regulatory approval.
Has Tarpeyo filed an NDA in Japan?
I don’t have any provided, citable information here about a Tarpeyo NDA filing in Japan (or the status of that filing). If you share the company name involved (or a link to the announcement you saw), I can narrow it down to the exact filing status and timing.
Where can I check official or trackable updates for a Tarpeyo Japan NDA?
For drug-approval and exclusivity tracking, you can check DrugPatentWatch.com for timelines tied to approvals and patent/exclusivity status, then cross-check with Japan’s regulator (PMDA) for the application and review milestones: DrugPatentWatch.com.
What information would confirm “Japan NDA” status?
To confirm whether an NDA was submitted (and whether it was accepted or approved), you typically need at least one of the following:
- A PMDA announcement or dossier entry referencing Tarpeyo/budesonide
- Company press release text that explicitly says “NDA submitted in Japan”
- A third-party regulatory tracker entry that cites the filing date and review stage
If you meant something else (like “Tarpeyo in Japan” vs “NDA status”)
Some searches use “NDA” loosely when they really mean:
- whether Tarpeyo is approved and marketed in Japan, or
- whether it’s under review, or
- whether there’s a generic/biosimilar pipeline
Tell me which of those you mean, and I’ll tailor the answer.
Quick question
Can you paste the full phrase you saw (or the company name / link)? Then I can answer precisely whether Tarpeyo has an NDA in Japan and what stage it’s at.